Iran joins elite ADC-producing countries with Tederox and Padynex, cutting costs by over 90 percent, expanding HER2-positive cancer treatment access, and showcasing rapid biopharmaceutical advancement despite sanctions.

Iran ranks fourth globally in high-impact research on advanced aircraft engines, including hypersonic propulsion, reflecting a focused, sanctions-resistant scientific strategy that has positioned it ahead of several traditional aerospace powers.

Iran Cancer Institute in Tehran has become West Asia’s largest cancer hospital, combining advanced treatment, research, education, and cutting-edge technologies while significantly expanding Iran’s regional and global standing in comprehensive cancer care and medical innovation.

Iran’s domestically developed ProSPECT II cardiac SPECT scanner has positioned it among a select group of countries capable of manufacturing advanced nuclear imaging systems, offering world-class diagnostic performance, lower costs, rapid servicing, and proven clinical reliability.

Iran's Jikan IAT-40, the world's first commercial ice adhesion tester, accurately measures ice shear stress for developing icephobic coatings and has been exported to European research institutions.

Iran uses advanced nuclear technology to screen every newborn for 58 metabolic disorders free of charge, saving thousands of them from brain damage and positioning itself as a global leader in nuclear medicine.

US-Israeli warplanes deliberately struck Tehran's 105-year-old Pasteur Institute – a national heritage site – as part of a systematic aggression against Iran's medical and research centers.